Twin Capital Management’s Zimmer Biomet ZBH Stock Holding History

Twin Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,116	Closed	-$616K	–	310
2020 Q4	$616K	Sell	4,116 -237	-5%	-$33.5K	0.06%	245
2020 Q3	$575K	Sell	4,353 -62	-1%	-$8.1K	0.05%	246
2020 Q2	$512K	Sell	4,415 -158	-3%	-$18.2K	0.05%	241
2020 Q1	$449K	Buy	4,573 +41	+0.9%	+$5.37K	0.05%	242
2019 Q4	$659K	Buy	+4,532	New	+$626K	0.06%	240
2013 Q4	–	Sell	-22,660	Closed	-$1.81M	–	329
2013 Q3	$1.81M	Buy	22,660 +412	+2%	+$32.4K	0.19%	160
2013 Q2	$1.62M	Buy	+22,248	New	+$1.66M	0.17%	156

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Twin Capital Management's ZBH Position: Q1 2021 in Review

Twin Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 4,116 shares — an estimated $616K sold.

Twin Capital Management first reported a position in ZBH in Q2 2013 and held it in 7 quarters. The position peaked at $1.81M in Q3 2013. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

Twin Capital Management reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
Twin Capital Management sold 4,116 Zimmer Biomet shares in Q1 2021, an estimated $616K.
Twin Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 7 quarters.
Twin Capital Management's Zimmer Biomet position peaked at $1.81M in Q3 2013.
1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Twin Capital Management's 13F filing for Q1 2021, filed 6 May 2021.